Q2 2026 Holdings
Filed 2026-08-14 | 67 holdings | $6.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc(GH) | COM | 40131M109 | $509.1M | 3,393,312 | 7.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $359.9M | 9,341,151 | 5.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $254.4M | 4,740,072 | 3.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $250.0M | 4,300,000 | 3.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $248.3M | 825,000 | 3.6% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $245.9M | 2,000,000 | 3.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $230.8M | 3,666,768 | 3.4% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $220.2M | 1,783,322 | 3.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $209.6M | 4,000,000 | 3.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $193.3M | 19,686,282 | 2.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $189.3M | 3,307,481 | 2.8% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $187.7M | 7,736,455 | 2.7% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $183.3M | 1,926,000 | 2.7% |
| Alumis Inc(ALMS) | COM | 022307102 | $178.6M | 6,348,558 | 2.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $174.4M | 2,200,000 | 2.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $172.1M | 12,161,496 | 2.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $171.6M | 4,000,000 | 2.5% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $171.3M | 700,000 | 2.5% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $155.2M | 5,650,000 | 2.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $136.3M | 6,999,025 | 2.0% |
| Hemab Therapeutics Hldgs Inc(COAG) | COM SHS | 423494103 | $132.3M | 3,602,093 | 1.9% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $131.3M | 4,200,000 | 1.9% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $129.4M | 2,750,000 | 1.9% |
| Grail Inc(GRAL) | COM | 384747101 | $125.3M | 1,834,944 | 1.8% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $121.7M | 4,100,000 | 1.8% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $111.4M | 3,732,569 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $109.4M | 2,939,151 | 1.6% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $108.8M | 3,352,804 | 1.6% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $95.6M | 1,732,569 | 1.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $89.6M | 3,333,334 | 1.3% |
| Genmab A/S(GMAB)Call | SPONSORED ADS | 372303206 | $82.4M | 3,000,000 | 1.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $77.4M | 2,000,000 | 1.1% |
| Ataibeckley Inc(ATAI) | COM SHS | 04650F101 | $76.0M | 14,417,442 | 1.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $67.0M | 123,616 | 1.0% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $66.7M | 3,610,000 | 1.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $66.0M | 3,592,740 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $59.6M | 700,000 | 0.9% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $58.5M | 19,250,000 | 0.9% |
| Personalis Inc(PSNL) | COM | 71535D106 | $53.6M | 4,000,000 | 0.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $49.4M | 9,345,000 | 0.7% |
| Cormedix Inc(CRMD) | COM | 21900C308 | $49.3M | 6,274,076 | 0.7% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $48.1M | 700,000 | 0.7% |
| Harrow Inc(HROW) | COM | 415858109 | $41.2M | 969,000 | 0.6% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $37.2M | 2,491,939 | 0.5% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $35.6M | 3,565,062 | 0.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $34.3M | 1,000,000 | 0.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $33.3M | 1,500,000 | 0.5% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $28.6M | 2,775,000 | 0.4% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $27.5M | 5,878,757 | 0.4% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $25.7M | 3,706,734 | 0.4% |